Latest Asx Filings News

Nelson Resources has initiated advanced geophysical surveys at its Gold Point Project in Nevada, aiming to unlock extensions of historically rich gold and silver veins ahead of maiden drilling in Q2 2026.

Regener8 Resources has announced a $2.03 million entitlement offer at a 41% discount, aiming to accelerate exploration and acquisition of its Srebrenica North Project. Eligible shareholders can subscribe at one new share for every two held, positioning the company for its next growth phase.

Carnaby Resources has released a compelling Pre-Feasibility Study and maiden Ore Reserve for its Greater Duchess Copper Gold Project, outlining a 12-year mine life with strong financial metrics and a near-term production target.

Aruma Resources has revealed promising soil sampling results from its Saltwater Project in Western Australia, highlighting a significant polymetallic and gold-bearing system with new priority targets. These findings set the stage for advanced exploration activities in 2026.

Ovanti Limited is reshaping its future with a strategic shift from its BNPL roots to a global financial Super App, exiting legacy US operations to focus on innovation and international expansion.

Latitude Group Holdings is considering launching a new Capital Notes 2 offer, potentially allowing existing CN1 holders to reinvest. The offer will require applications through appointed Syndicate Brokers under updated regulatory rules.

Barton Gold Holdings has launched Phase 2 drilling at its Tunkillia Gold Project, aiming to upgrade resources and fast-track a mining lease application by year-end. The project’s strong economics and rising gold and silver prices underpin an optimistic development outlook.

Jupiter Mines has announced a modest interim dividend of 0.55 cents per share for H1 FY2026, reflecting ongoing shareholder returns despite a lower payout ratio compared to previous years.

Dataworks Group Limited reveals ongoing strategic review with several parties engaged, highlighting the value of its self-exclusion technology and regulatory ties. While discussions remain preliminary, the company signals potential for significant strategic moves ahead.

Dimerix Limited is set to conduct a blinded statistical review of its pivotal Phase 3 ACTION3 study in March 2026, aiming to confirm the trial remains powered to demonstrate the primary endpoint of proteinuria reduction in FSGS patients.

Ore Resources Ltd has acquired four new prospecting licenses adjacent to its Coolgardie Gold and Lithium Project, expanding its landholding to over 80 square kilometres. The company plans systematic exploration targeting promising historical gold intercepts, with drilling set for early Q3 2026.

Tetratherix Limited launches a new precision medicine franchise leveraging its Tetramatrix™ platform, securing a decade-long exclusive partnership with US health group Superpower Health Inc. This deal promises immediate revenue and complements ongoing FDA milestones.